Founded in 2001, our group is a globally recognized peptide company and a leading Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in the production of synthetic peptides and oligonucleotides. The company’s leadership team comprises seasoned professionals with over three decades of experience in chemical manufacturing, peptide and oligonucleotide chemistry, and therapeutic development. Their deep industry knowledge and strategic oversight continue to drive CPC Scientific’s growth and innovation, reinforcing its position as a trusted partner to pharmaceutical, biotechnology, and academic institutions worldwide. Through their leadership, CPC Scientific remains committed to advancing the development and commercialization of complex therapeutics with the highest standards of quality and scientific excellence.